A recent study, utilizing RNA sequencing, followed by validation at both protein and mRNA levels, revealed that S100A8 was specifically enriched in MPN-model cells harboring the CALR type 1 mutation (52 bp deletion) compared to those with the CALR type 2 mutation (5 bp insertion) [64]. The gene discussed is S100A8; the disease is myeloproliferative neoplasm.